Drug Shortage Report for REPAGLINIDE
Report ID | 35070 |
Drug Identification Number | 02415968 |
Brand name | REPAGLINIDE |
Common or Proper name | REPAGLINIDE |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | REPAGLINIDE |
Strength(s) | 0.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A10BX |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-11-15 |
Estimated end date | |
Actual end date | 2019-01-11 |
Shortage status | Resolved |
Updated date | 2019-01-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-01-05 | English | Compare |
v2 | 2018-01-05 | French | Compare |
v3 | 2018-02-13 | English | Compare |
v4 | 2018-02-13 | French | Compare |
v5 | 2018-03-20 | English | Compare |
v6 | 2018-03-20 | French | Compare |
v7 | 2018-03-26 | English | Compare |
v8 | 2018-03-26 | French | Compare |
v9 | 2018-04-03 | English | Compare |
v10 | 2018-04-03 | French | Compare |
v11 | 2018-11-15 | English | Compare |
v12 | 2018-11-15 | French | Compare |
v13 | 2018-11-16 | English | Compare |
v14 | 2019-01-08 | English | Compare |
v15 | 2019-01-08 | French | Compare |
v16 | 2019-01-11 | English | Compare |
v17 | 2019-01-11 | French | Compare |
v18 | 2019-01-12 | English | Compare |
Showing 1 to 18 of 18